SCHEMBL6837746

SCHEMBL6837746

FC(F)(F)c1nc2ccc(Cl)cc2c2c1nc(-c1ccccc1)n2CCC1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 3/20 0.41
PIM1 P11309 2/20 0.39
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
S1PR2 O95136 1/20 0.38
KMT2A Q03164 1/20 0.38
HIF1A Q16665 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ACP1 P24666 3/20 0.38
EGFR P00533 1/20 0.36
SLC6A4 P31645 1/20 0.35
CNR2 P34972 1/20 0.35
HTT P42858 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TRIM58 Q8NG06 2/20 0.35
MERTK Q12866 1/20 0.35
PDE6D O43924 1/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837686 0.94 EGFR (0.41) NPY1RPIM1KDM4ELMNAS1PR2
SCHEMBL6838674 0.90 ADRB2 (0.39) NPY1RLMNAHIF1AHTTTRIM58
SCHEMBL6930321 0.89 NPY1R (0.43) NPY1RPIM1KDM4ELMNAS1PR2
SCHEMBL6833713 0.89 NPY1R (0.39) NPY1RACP1SLC6A4MERTKPDE6D
SCHEMBL7493968 0.87 ACP1 (0.40) NPY1RLMNAHIF1AACP1TRIM58
SCHEMBL7493132 0.86 ACP1 (0.38) NPY1RPIM1KDM4EKMT2AACP1
SCHEMBL6833817 0.85 KHK (0.38) NPY1RTRIM58MERTKPDE6D
SCHEMBL6833986 0.85 AVPR2 (0.35) NPY1RACP1TRIM58MERTKPDE6D
SCHEMBL6837773 0.85 NPY1R (0.38) NPY1RPIM1KDM4ELMNAKMT2A
SCHEMBL6838600 0.85 NPY1R (0.38) NPY1RPIM1KDM4ELMNAACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 NPY1R 1070/4885PIM1 261/4885KDM4E 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.